First, as an oncogene that is overexpressed in HCC, the impact of LYRM2 knockdown in HCC cells on the in vivo growth and metastasis may be more pronounced than that of LYRM2 overexpression. The gene discussed is LYRM2; the disease is hepatocellular carcinoma.